-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322.P1.60 322. Disorders of Coagulation or Fibrinolysis: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, antibodies, Biological, Bleeding Disorders, Coronaviruses, Hemophilia, SARS-CoV-2/COVID-19, Bleeding and Clotting, Diseases, Hemostasis, Non-Biological, Combinations, Therapies, Genetic Disorders, Pediatric, coagulant drugs, Pregnancy, infusion, Study Population, Thromboembolism, Clinically relevant, pharmacology, VTE, VWD
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Sarah A Hale, MS, PhD1*, Alexander Bauer2*, Giovanni Smania3*, Sofia Friberg-Hietala3* and Martin J Wolfsegger, PhD2*

1Bleeding Disorders, Takeda Pharmaceutical Company Limited, Lexington, MA
2Baxalta Innovations GmbH, a Takeda company, Vienna, MA, Austria
3Pharmetheus AB, Uppsala, Sweden

Amy D Shapiro, MD1, Barbara A. Konkle, MD2,3, Stacy E. Croteau, MD4, Wolfgang A. Miesbach, MD, PhD5*, Charles Richard Morris Hay, MD, FRCP, FRCPath6, Rashid Kazmi, MBBS7*, Marina Mihova8*, Savita Rangarajan, MD, MBBS9 and John Pasi, MB, ChB, PhD, FRCP, FRCPath, FRCPCH10

1Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
2University of Washington, Seattle, WA
3University of Washington, Washington Center for Bleeding Disorders, Seattle, WA
4Boston Children's Hospital, Boston, MA
5Hemophilia Centre, University Hospital Frankfurt, Frankfurt, Germany
6Manchester Royal Infirmary, Manchester, United Kingdom
7University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
8Sigilon Therapeutics, Cambridge, MA
9University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, Southampton, United Kingdom
10Barts and the London School of Medicine and Dentistry, London, United Kingdom

Gavin Ling, MBBS, FRCPath, PhD1, Aderonke Ajidahun, RN2*, Steve K. Austin, BMedSci, MBBS2*, Gerard Dolan, MBChB, FRCP, FRCPath2* and Aine McCormick, PhD2*

1Department of Haematology, Guy's & St Thomas' NHS Foundation Trust, London, Eng, United Kingdom
2Haemostasis and Thrombosis Centre, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

Shaobin Wang, PhD1*, Sravya Kattula, PhD2*, Ayman Ismail, PhD3*, Nina Leksa, PhD4*, Arjan van Der Flier, PhD5* and Joe Salas, PhD5

1Rare Disease: Hemophilia, sanofi, Waltham, MA
2Rare Disorder: Hemophila, Sanofi, Waltham, MA
3Rare Disorders: Hemophila, Sanofi, Waltham, MA
4Rare Disorders: Hemophilia, Sanofi, Waltham, MA
5Rare Disease: Hemophilia, Sanofi, waltham, MA

Kanza Naveed1*, Grace H Tang, MSc2*, McKenzie Quevillon, RN, BScN, MN1*, Filomena Meffe, MD, MSc3*, Rachel Martin, MD4*, Jillian M Baker, MD, MSc5,6* and Michelle Sholzberg, MDCM, FRCPC, MSc7,8,9

1Department of Hematology and Oncology, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada
2Division of Hematology-Oncology, Department of Medicine, St. Michael’s Hospital, Toronto, ON, Canada
3Department of Obstetrics and Gynecology, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada
4Department of Anesthesia, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
5Department of Pediatrics, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
6Department of Paediatrics, The Hospital for Sick Children, Toronto, Canada
7Department of Hematology and Oncology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
8Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
9Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada

Claudia Khayat, MD, BS 1*, Irina Kruzhkova2*, Cristina Solomon2*, Bruce A. Schwartz, PhD3 and Flora Peyvandi4

1Department of Pediatrics, Hotel Dieu de France, Beirut, Lebanon
2Octapharma AG, Lachen, Switzerland
3Octapharma US, Atlantic City, NJ
4Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Neelan Sriranjan, MD1*, Donald S. Houston, MD, PhD2, Sara J. Israels, MD3, Emily Rimmer, MD, FRCPC2,4, Tracy Nacionales, RN, BN5* and Tracy Voth, RN, BN5*

1Internal Medicine, University of Manitoba, winnipeg, MB, Canada
2Section of Hematology and Medical Oncology, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
3Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada
4University of Manitoba / CancerCare Manitoba, Winnipeg, MB, Canada
5Pediatric Hematology, University of Manitoba, Winnipeg, Canada

Arash Mahajerin1, Rahul Khairnar2*, Craig S. Meyer2*, Ibrahim M. Abbass2*, Rongrong Wang2*, Lucy Lee2*, Eunice Tzeng2* and Karina Raimundo2*

1CHOC Children's Hospital, Orange, CA
2Genentech, Inc., South San Francisco, CA

Beatrice Nolan, FRCPath1*, Anna Klukowska, MD, PhD2*, Amy D Shapiro, MD3, Antoine Rauch4*, Michael Recht, MD, PhD5, Margaret V. Ragni, MD, MPH6, Julie Curtin7, Sriya Gunawardena8*, Stacey Poloskey8*, Deepthi Jayawardene8*, Bent Winding9*, Kathelijn Fischer10* and Raina Liesner11*

1Children Health Ireland at Crumlin, Dublin, Ireland
2Medical University of Warsaw, Warsaw, Poland
3Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
4Lille University Hospital Center (CHU) Lille, Lille, France
5Oregon Health and Science University, Portland, OR
6University of Pittsburgh Medical Center, Pittsburgh, PA
7The Children's Hospital at Westmead, Sydney, NSW, Australia
8Sanofi, Waltham, MA
9Swedish Orphan Biovitrum AB (Sobi), Stockholm, Sweden
10University Medical Center Utrecht, Utrecht, Netherlands
11Great Ormond Street Hospital, London, United Kingdom

Margaret V. Ragni, MD, MPH1, Frederico Xavier, MD, MS2, Craig D. Seaman3, Suchitra Acharya, MD4, Catherine E. McGuinn, MD5, Eric J. Werner, MD6*, Courtney Elizabeth Lawrence, MD, MS7*, Allison P. Wheeler, MD8, Ulrike Reiss, MD9, Irmel Ayala, MD10*, Erin Cockrell, DO11, Cristina Tarango, MD12, Amy Dunn13, Roshni Kulkarni, MD14, Sanjay P Ahuja, MD15, Meera B. Chitlur, MD16, Steven W. Pipe, MD17, Lynn M Malec, MD18, Vilmarie Rodriguez, MD19, Shelley Crary, MD, MS20, Deborah Brown, MD21, Rosa Diaz, MD22*, Maria Velez, MD23*, Cindy A. Leissinger, MD24, Shannon L Carpenter, MD25, Christine M. Knoll, MD26, Michael Wang, MD27, Guy Young, MD28, Courtney D Thornburg, MD29, Joseph L Lasky III, MD30*, Tiffany Lin Lucas, MD31, Nina Hwang, MD32*, Deborah Vehec, MSN, RN33*, Dana Ivanco34*, Tamara L. Haller, BS35*, Marnie Bertolet, PhD36* and Maria M Brooks, PhD37*

1University of Pittsburgh Medicine, Division Hematology/Oncology, Pittsburgh, PA
2Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center and Hemophilia Center of Western PA, Pittsburgh, PA
3University of Pittsburgh, Warrendale, PA
4Pediatric Hematology, Oncology and Cellular Therapy, Cohen Children's Medical Center of New York, New Hyde Park, NY
5Weill Cornell Medical College, New York, NY
6Children's Hospital of The King's Daughters, Norfolk, VA
7Division of Pediatric Hematology / Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
8Dept. of Pediatric Hem./Onc., Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN
9Department of Surgery, St. Jude Children's Rsch. Hosp., Memphis, TN
10Pediatric Cancer and Blood Disorders Center, Johns Hopkins All Children's Outpatient Care Center, St. Petersburg, FL
11St. Joseph's Children's Hospital, Tampa, FL
12Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
13Nationwide Children's Hospital, Columbus, OH
14Michigan State University Center for Bleeding and Clotting Disorders, East Lansing, MI
15University Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, Cleveland, OH
16Hemostasis and Thrombosis Center, Children's Hospital of Michigan, Detroit, MI
17Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI
18Blood Research Institute, Versiti, Milwaukee, WI
19Division of Pediatric Hematology, Mayo Clinic, Rochester, MN
20University of Arkansas for Medical Sciences, Little Rock, AR
21Department of Pediatrics- Hematology Division, University of Texas Health Science Center at Houston, Houston, TX
22Texas Children's Hospital, Houston, TX
23Children's Hospital New Orleans, Louisiana State University, New Orleans, LA
24Tulane University, New Orleans, LA
25Children's Mercy Hospital, Kansas City, MO
26Arizona Hemophilia and Thrombosis Center, Phoenix Children's Hospital, Phoenix, AZ
27Anschutz Medical Campus, University of Colorado, School of Medicine, Hemophilia and Thrombosis Center, Aurora, CO
28University of Califormia Los Angeles, Children's Hospital Los Angeles, Los Angeles, CA
29Rady Children's Hospital, San Diego, CA
30University of Nevada, Cure 4 the Kids Foundation, Las Vegas, NV
31University of California, San Francisco, San Francisco, CA
32CHOC Children's Hospital, Orange County, Center for Inherited Blood Disorders (CIBD), Orange, CA
33Hemophilia Center of Western PA, Institute for Transfusion Medicine, Vitalant, Pittsburgh, PA
34Institute for Transfusion Medicine, Hemophilia Center of Western PA, Pittsburgh, PA
35Department of Epidemiology, Epidemiology Data Center, University of Pittsburgh, Pittsburgh, PA
36Epidemiology Data Center, University of Pittsburgh, Pittsburgh, PA
37Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA

Guilherme Sacchi De Camargo Correia, MD1*, Sridevi Rajeeve, MD2 and Lawrence Cytryn, MD3

1Department of Medicine, Icahn School of Medicine at Mount Sinai West and Morningside, New York, NY
2Division of Hematology and Oncology - Department of Medicine, Icahn School of Medicine At Mount Sinai Hospital, New York, NY
3Division of Hematology and Oncology - Department of Medicine, Icahn School of Medicine at Mount Sinai West and Morningside, New York, NY

Janna M. Journeycake, MD1, Michael Recht, MD, PhD2, Christine Guelcher, Hemostasis RN-BC, MS, PPCNP-BC3*, Ellis J. Neufeld4, Margaret V. Ragni, MD, MPH5, Robert F. Sidonio Jr., MD, MSc.6, Cliff Takemoto7*, Michael D Tarantino, MD8, Dunlei Cheng, PhD2*, Susan U. Lattimore, R.N.9*, Jorge Caicedo10* and Michael Denne, PharmD11

1Jimmy Everest Center for Cancer and Blood Disorders, University of Oklahoma Health Sciences Center, Oklahoma City, OK
2American Thrombosis and Hemostasis Network, Rochester, NY
3Children's National Health System, Center for Cancer and Blood Disorders, Washington, DC
4St. Jude Children's Research Hospital, Memphis, TN
5Department of Medicine - Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA
6Hemophilia of Georgia Center for Bleeding and Clotting Disorders, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Decatur, GA
7St. Jude Research Hospital, Memphis, TN
8Bleeding & Clotting Disorders Institute, Peoria, IL
9The Hemophilia Center, Oregon Health & Science University, Portland, OR
10Takeda Pharmaceuticals U.S.A., Inc, Boston, MA
11Takeda, Cambridge, MA

Daniel Lindsay1*, Jerome M. Teitel, MD, FRCPC2,3 and Michelle Sholzberg, MDCM, FRCPC, MSc4,5,6,7

1Hematology-Oncology Clinical Research Group, St. Michael's Hospital, Toronto, ON, Canada
2Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON, Canada
3Department of Medicine, University of Toronto, Toronto, ON, Canada
4University of Toronto, Toronto, ON, Canada
5Division of Hematology/Oncology, St. Michael’s Hospital, Toronto, ON, Canada
6Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada
7Department of Laboratory Medicine and Pathobiology, St. Michael’s Hospital, Toronto, ON, Canada

Evan C. Chen, MD1, William J. Gibson, MD, PhD1*, Paula Temoczko, NP2*, Nathan T. Connell, MD, MPH2, Robert Handin, MD2* and Aric D. Parnes, MD2

1Dana Farber Cancer Institute, Boston, MA
2Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA

Saad Z Ahmed, MBBS1, Michelle O’Rourke, FACSLM2*, Vince Jenkins, PhD3*, Caitriona Keenan, PhD3*, Irene Ellen Regan, BSc, FRCPath, MBA4* and Beatrice Nolan, FRCPath5*

1Haematology Department, National Coagulation Cenre, Dublin, Dublin, Ireland
2Hematology Department, Children's Health Ireland at Crumlin, Dublin, Ireland
3St. James's Hospital, National Coagulation Centre, Dublin, Ireland
4Children Health Ireland at Crumlin, Dublin 12, IRL
5Children Health Ireland at Crumlin, Dublin, Ireland

Gili Kenet1,2, Thomas Moulton, MD3, Erika Soltes Rak3*, Brian M. Wicklund, MD, MPH4 and Sanjay P Ahuja, MD5

1National Hemophilia Center, Sheba Medical Center, Tel HaShomer, Israel
2The Amalia Biron Thrombosis Research Institute, Tel Aviv University, Tel Aviv, Israel
3Bayer, Whippany, NJ
4Children’s Mercy-Kansas City, Kansas City, MO
5Rainbow Babies & Children’s Hospital, Cleveland, OH

Mark Crowther, MD1, David A. Garcia, MD2, Jason Hill, MD, MSc3*, Bryan Savage4*, Shira Peress5*, Kevin Chang6* and Steven Deitelzweig, MD7*

1McMaster University, Hamilton, ON, Canada
2Division of Hematology, University of Washington School of Medicine, Seattle, WA
3Ochsner Health and University of Queensland, Slidell, LA
4Ochsner Health, Jefferson, LA
5Ochsner, Jefferson, LA
6Oschner Health and University of Queensland, Jefferson, LA
7Department of Hospital Medicine, Ochsner Clinic Foundation, New Orleans, LA

Mo Yang1,2*, Huixia Deng3*, Liuming Yang1*, Liang Li, PhD2*, Jieyu Ye, PhD3*, Yucai Cheng4*, Yafang Tan5*, Beng H Chong, MBBS, PhD6,7 and Qiang Li8*

1Lianjiang People's Hospital, Lianjiang, China
2The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
3Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
4The seventh affiliated hospital, Sun Yat-sen University, Shenzhen, China
5Department of Otolaryngology, Nanfang Hospital, Southern Medical University, Guangzhou, China
6Medicine, University of New South Wales, Kogarah, Australia
7St George Hospital, Sydney, Australia
8Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China

Sylvia Von Mackensen1*, Pratima Chowdary2*, Sarah Mangles3*, Qifeng Yu4*, Baisong Mei4, Shauna R. Andersson4* and Pronabesh Dasmahapatra, MBBS, MPH4*

1Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
2Katharine Dormandy Haemophilia and Thrombosis Centre Unit, Royal Free Hospital, London, United Kingdom
3Haemophilia, Haemostasis and Thombosis Centre, Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom
4Sanofi, Cambridge, MA

Alexander Solms1*, Anita Shah2*, Sara Wiegmann3*, Maurice Ahsman4*, Erik Berntorp5*, Andreas Tiede, MD6, Alfonso Iorio, MD, PhD7, Maria Elisa Mancuso8*, Tihomir Zhivkov9* and Toshko Lissitchkov9*

1Bayer, Berlin, Germany
2Bayer, Whippany
3Bayer, Wuppertal, Germany
4LAP&P Consultants BV, Leiden, Netherlands
5Centre for Thrombosis and Haemostasis, Lund University, Skåne University Hospital, Malmö, Sweden
6Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
7McMaster-Bayer Endowed Research Chair in Clinical Epidemiology of Congenital bleeding Disorders, Department of Medicine, McMaster University, Hamilton, Canada
8Center for Thrombosis and Hemorrhagic Diseases, Humanitas Clinical and Research Center – IRCCS, Milan, Italy
9Specialized Hospital for Active Treatment, Sofia, Bulgaria

*signifies non-member of ASH